Da Fonseca, L.G.; Hashizume, P.H.; de Oliveira, I.S.; Izquierdo-Sanchez, L.; Saud, L.R.d.C.; Xerfan, M.P.; Alves, V.A.F.; de Mello, E.S.; Herman, P.; Banales, J.M.;
et al. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers 2022, 14, 3483.
https://doi.org/10.3390/cancers14143483
AMA Style
Da Fonseca LG, Hashizume PH, de Oliveira IS, Izquierdo-Sanchez L, Saud LRdC, Xerfan MP, Alves VAF, de Mello ES, Herman P, Banales JM,
et al. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers. 2022; 14(14):3483.
https://doi.org/10.3390/cancers14143483
Chicago/Turabian Style
Da Fonseca, Leonardo G., Pedro H. Hashizume, Irai Santana de Oliveira, Laura Izquierdo-Sanchez, Lisa Rodrigues da Cunha Saud, Mariana Pinheiro Xerfan, Venancio Avancini Ferreira Alves, Evandro Sobroza de Mello, Paulo Herman, Jesus M. Banales,
and et al. 2022. "Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence" Cancers 14, no. 14: 3483.
https://doi.org/10.3390/cancers14143483
APA Style
Da Fonseca, L. G., Hashizume, P. H., de Oliveira, I. S., Izquierdo-Sanchez, L., Saud, L. R. d. C., Xerfan, M. P., Alves, V. A. F., de Mello, E. S., Herman, P., Banales, J. M., Oliveira, C. P., & Carrilho, F. J.
(2022). Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers, 14(14), 3483.
https://doi.org/10.3390/cancers14143483
